Li X, Yuan H J, Tian X M, Tang J, Liu L F, Liu F Y
Department of Interventional Radiology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, PR China.
Department of Gerontology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310006, PR China.
Mater Today Bio. 2021 Aug 25;12:100128. doi: 10.1016/j.mtbio.2021.100128. eCollection 2021 Sep.
Transcatheter arterial embolization has been considered as a promising targeted delivery approach for hepatocellular carcinoma (HCC). Currently, chemoembolization was the main treatment for unresectable HCC. However, the traditional chemoembolization treatment suffers from undesirable therapeutic effects and serious side-effects. In this study, the doxorubicin (DOX)-encapsulated and near-infrared (NIR)-responsible copper sulfide (CuS)-based nanotherapeutics was developed for magnetic resonance imaging (MRI)-guided chemo-photothermal therapy of HCC tumor in rats. The DOX-loaded CuS nanocomposites (DOX@BSA-CuS) demonstrated distinct NIR-triggered drug release behavior and high photothermal effect. In an orthotopic HCC rat model, DOX@BSA-CuS nanocomposites were selectively delivered to the tumor site the intra-arterial transcatheter. The proposed DOX@BSA-CuS nanocomposites plus NIR laser irradiation exhibited significant tumor growth suppression performance. Moreover, the treatment progress can be monitored by MRI images. Finally, the preliminary toxicity estimate suggested the negligible side-effect of DOX@BSA-CuS nanocomposites during the therapeutic process. These results suggest the clinical translational potential possibility for imaging-guided arterial embolization with DOX@BSA-CuS nanocomposites for the treatment of HCC.
经导管动脉栓塞术被认为是一种有前景的肝细胞癌(HCC)靶向递送方法。目前,化疗栓塞是不可切除HCC的主要治疗方法。然而,传统的化疗栓塞治疗存在不良治疗效果和严重副作用。在本研究中,开发了用于大鼠HCC肿瘤磁共振成像(MRI)引导下化疗-光热治疗的载有阿霉素(DOX)且对近红外(NIR)有响应的硫化铜(CuS)基纳米治疗剂。载有DOX的CuS纳米复合材料(DOX@BSA-CuS)表现出明显的近红外触发药物释放行为和高光热效应。在原位HCC大鼠模型中,通过动脉内导管将DOX@BSA-CuS纳米复合材料选择性递送至肿瘤部位。所提出的DOX@BSA-CuS纳米复合材料加近红外激光照射表现出显著的肿瘤生长抑制性能。此外,治疗过程可通过MRI图像进行监测。最后,初步毒性评估表明DOX@BSA-CuS纳米复合材料在治疗过程中的副作用可忽略不计。这些结果表明,DOX@BSA-CuS纳米复合材料用于HCC治疗的成像引导动脉栓塞术具有临床转化的潜在可能性。
Biomaterials. 2014-4-22
Nan Fang Yi Ke Da Xue Xue Bao. 2021-12-20
J Colloid Interface Sci. 2018-12-19
Mater Today Bio. 2025-8-13
Front Mol Biosci. 2025-5-13
J Mater Sci Mater Med. 2025-4-25
Biomater Res. 2023-11-24
Nanomicro Lett. 2020-7-5
ACS Appl Mater Interfaces. 2019-5-30